Carol-Ann Ohmstede
Keine laufenden Positionen mehr
Profil
Carol-Ann Ohmstede joined Trimeris, Inc. in 1998 as Vice President of Project Planning and was promoted to Vice President of Corporate Alliances and Project Planning in 2001.
Prior to joining Trimeris, she held various positions in the Research and Development Division of Burroughs Wellcome, Inc. and Glaxo Wellcome.
Dr. Ohmstede received a BA and a PhD in Biochemistry from the University of South Florida College of Medicine.
Ehemalige bekannte Positionen von Carol-Ann Ohmstede
| Unternehmen | Position | Ende |
|---|---|---|
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Corporate Officer/Principal | - |
Ausbildung von Carol-Ann Ohmstede
| University of South Florida | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | Health Technology |
